To obtain more insight for the significance of FMRP target candidate genes, we focused on the three criteria, i.e., neurogenesis, ID, and ASD since FXS patients often show ID and ASD symptoms [8, 9]. This evidence concerns the gene FMR1 and fragile X syndrome.